Morning Regulatory Review: Contraception Regulations Revision; Advisory Committee Appointments; Orphan Drugs

Morning Regulatory Review:  Contraception Regulations Revision; Advisory Committee Appointments; Orphan Drugs

A number of volatile issues made ripples in regulatory practice last week that will not be found in the general media.  The saga of the religious exemption from the contraceptives mandate in Obamacare (Patient Protection and Affordable Care Act or PPACA) added an introduction to a new chapter last week when the Department of Justice (DOJ) committed the Department of Health and Human Services (HHS) and its cohorts to a plan for new regulations.